The trusted source for
healthcare information and
The Center for Drug Evaluation and Research (CDER) lists drugs that are currently in short supply on the Food and Drug Administration Web site. The information may help pharmacists pacify doctors and patients who can’t understand why they can’t get the drug they need, in the formulation they need. The following is the drug shortage listing as of the end of January.
• Fentanyl (Taylor/Akorn, Abbott, ESI Lederle):
• Isuprel and Isoproterenol Injection (Abbott):
• Mesantoin (mephenytoin) (Novartis Pharmaceuticals):
• Quinidine Gluconate (Eli Lilly, available through CDC Malaria Hotline):
• Romazicon (flumazenil) (Roche Pharmaceuticals):
Products with limited distribution and those whose shortage has been resolved appear in separate lists on the following Web site: www.fda.gov/cder/drug/shortages/default.htm. To report a drug shortage, health professionals and patients may contact CDER Drug Information at (888) INFOFDA or (888) 463-6332.